Cargando…
β-Hydroxybutyrate in Cardiovascular Diseases : A Minor Metabolite of Great Expectations
Despite recent advances in therapies, cardiovascular diseases ( CVDs ) are still the leading cause of mortality worldwide. Previous studies have shown that metabolic perturbations in cardiac energy metabolism are closely associated with the progression of CVDs. As expected, metabolic interventions c...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234267/ https://www.ncbi.nlm.nih.gov/pubmed/35769904 http://dx.doi.org/10.3389/fmolb.2022.823602 |